Vivos (RDGL) Shares Outstanding (2010 - 2026)
Vivos (RDGL) posted Shares Outstanding (Entity) of $455.5 million for Q4 2025, little changed sequentially from $454.7 million in Q3 2025, and up 3.32% YoY from $440.9 million in Q4 2024.
Vivos (RDGL) Shares Outstanding (2010 - 2026) Analysis & Trends
Vivos has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $455.5 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 3.32% year-over-year to $455.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $455.5 million (up 3.32% YoY) and the FY2025 annual result came in at $455.5 million, up 3.32% from the prior year.
- Shares Outstanding (Entity) held at $455.5 million in Q4 2025 per RDGL's latest filing, from $454.7 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $455.5 million in Q4 2025 and troughed at $320.3 million in Q1 2021.
- A 5-year average of $386.0 million and a median of $370.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) surged 93.39% in 2021, then advanced 2.68% in 2022.
- Over 5 years, Shares Outstanding (Entity) stood at $343.5 million in 2021, then gained by 5.53% to $362.5 million in 2022, then increased by 6.99% to $387.9 million in 2023, then grew by 13.66% to $440.9 million in 2024, then rose by 3.32% to $455.5 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $455.5 million, $454.7 million, and $453.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | 452.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 490.70 Mn |
| Dec 31, 2025 | 452.72 Mn |
| Sep 30, 2025 | 454.30 Mn |
| Jun 30, 2025 | 453.51 Mn |
| Mar 31, 2025 | 448.23 Mn |
| Dec 31, 2024 | 409.67 Mn |
| Sep 30, 2024 | 418.63 Mn |
| Jun 30, 2024 | 403.38 Mn |
| Mar 31, 2024 | 389.41 Mn |
| Dec 31, 2023 | 368.81 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 368.17 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 351.43 Mn |
| Sep 30, 2022 | 358.75 Mn |
| Jun 30, 2022 | 343.91 Mn |
| Mar 31, 2022 | 343.61 Mn |
| Dec 31, 2021 | 325.85 Mn |
| Sep 30, 2021 | 335.51 Mn |
| Jun 30, 2021 | 328.22 Mn |